M. Holland Company Announces New Global Healthcare Group for Medical Device Manufacturers

February 6, 2018 • Posted in News

M. Holland Healthcare Group assists customers in medical device program development, services, and policy guidance

Northbrook, IL, Febraury 06, 2018 – M. Holland Company, a leading distributor of thermoplastic resin, announces the formation of the M. Holland Healthcare Group, which provides targeted services and medical-grade resin products, including K-Resin® and ZYLAR®, available immediately for medical device manufacturers across North America and Latin America.

The M. Holland Healthcare Group expands M. Holland’s plastics distribution into the growing healthcare market, and provides a full line of medical-grade resins with regulatory documentation, change notification, and medical technical experts that work alongside customers from product development through manufacturing. The M. Holland Healthcare Group creates a personal, seamless purchasing experience for medical customers, and offers guidance in selecting resins suitable for safe medical device development.

“M. Holland has engineered an industry-leading medical-grade product portfolio, combined with technical services and commercial resources that our medical customers and suppliers can trust,” said Josh Blackmore, global healthcare manager for M. Holland. “We source global medical-grade resins of the highest consistency and quality, and only work with suppliers that have demonstrated a continuous commitment to the healthcare industry. We aim to be the healthcare industry’s complete resins provider with the highest levels of personal service, consistency, reliable supply, and accessibility in the market.”

In addition to globally sourced medical-grade resin, the M. Holland Healthcare Group provides healthcare customers with change management tools such as formulation control; change notification; supply chain risk assessment and specific tools to reduce burdens for when change is unavoidable.

M. Holland’s expertly sourced medical-grade resins have undergone biocompatibility testing that meets ISO 10993 protocols or those of a governing pharmacopeia such as USP Class VI, and include the following products, and more:

  • INEOS Styrolution materials including K-Resin® SBC, CLEARBLEND®, LUSTRAN®, STYROFLEX®, and ZYLAR®
  • BASF materials including ULTRAFORM®, ULTRADUR®, and ULTRASON®
  • Chevron Phillips Chemical Company materials including MARLEX®, MARFLEX®, and mPACT®
  • Covestro materials including Apec®, Bayblend®, Makrolon®, and Makroblend®
  • Elastron materials including SEBS and TPV
  • Total Petrochemicals & Refining USA materials’ line of polypropylene (homopolymer, random copolymer, and impact copolymer) and polyethylene (HDPE) products

The M. Holland Healthcare Group is part of the company’s Business Development Group and integral to its strategy to expand targeted services and products for key end markets. M. Holland will be exhibiting at MD&M West 2018, Feb. 6-8, in booth #3808. Medical device manufacturers and suppliers wishing to meet during the show should contact jblackmore@mholland.com. Interested members of the press should contact MHolland@ink-co.com.


M. Holland is a leading international distributor of thermoplastic resin, providing suppliers the most strategic channels to market, offering innovative sourcing and supply chain solutions to its clients, and helping people lead rewarding careers. Since 1950, a deep commitment to personal relationships has formed the core of the company’s heritage, its culture, and its vision. Headquartered in Northbrook, Ill., M. Holland sells in excess of 1.4 billion pounds of resin to more than 4,000 clients annually. To learn more, visit www.mholland.com. Follow M. Holland on Twitter, LinkedIn, and Facebook.


INK Communications for M. Holland
Caitlin New, 512.906.9103

Stay informed with industry trends and insights.